Vanderbilt Eye Institute

Since 1961, the Eye Bank Association of America has provided donors for more than 1.5 million corneal transplants nationwide. And for nearly 25 years, the group has celebrated corneal transplant recipients, promoted awareness of the need to donate and recognized donors and families during National Eye Donor Month in March. Read More

The Vanderbilt Eye Institute (VEI) was recently awarded the Commitment to Advocacy Award during the Association of University Professors of Ophthalmology (AUPO) annual meeting. Read More

Tonia Rex, Ph.D., and colleagues at the Vanderbilt Eye Institute are working to uncover how best to treat ocular trauma, the fourth leading cause of blindness worldwide. Read More

Sight is one of the most critical elements of a normal, happy life. When a child’s eyesight is threatened, his or her future stands to be permanently altered — and parents try to find the best treatment available. Read More

Vision science at Vanderbilt has experienced tremendous growth in recent years. Read More

Vanderbilt investigator Anthony Daniels has received a grant from the Knights Templar Eye Foundation to develop new, safe and effective treatments for retinoblastoma, the most common ocular cancer in children. Read More

The Vanderbilt Eye Institute recently received a grant for $115,000 from Research to Prevent Blindness, placing the total award amount for unrestricted grants from the organization at $860,000. Read More

For the past few months, much of the nation has donned hats, boots, scarves and gloves as they face brutally cold and icy conditions of winter. As temperatures rise, making outdoor activities more enticing, Vanderbilt ophthalmologists suggest not to be in such a hurry to stop protecting… Read More

John Penn, Ph.D., Phyllis G and William B. Snyder Endowed Professor of Ophthalmology and Visual Sciences, has been named president-elect of the International Society for Eye Research (ISER). Read More

Vanderbilt Eye Institute’s Initiative for Personalized Medicine in Ophthalmology looks for biomarkers that determine a person’s risk of developing any of the three leading causes of blindness. Read More

Understanding how the protein TRPV1 helps neurons survive after glaucoma-related stressors could lead to new therapeutic strategies for glaucoma and other neurodegenerative conditions. Read More

It’s been 20 years since Project PAVE, a Tennessee program providing low-vision evaluations for children, was launched. Read More

Conventional therapy for patients diagnosed with retinoblastoma, the most common ocular cancer in children, includes systemic chemotherapy, external beam radiation and/or surgical removal of the eye. Doctors at Vanderbilt University Medical Center are on track to radically change the way the disease is treated using an emerging therapeutic approach called intra-arterial chemotherapy, or IA chemo. Read More

A person’s mitochondrial gene “signature” could predict risk for diabetic retinopathy and guide early intervention strategies. Read More

Understanding the cellular and molecular responses of the eye to blast injury could guide new treatment development. Read More

Laura Wayman, M.D., associate professor of Ophthalmology and Visual Sciences, has been awarded the 2014 Straatsma Award for Excellence in Resident Education. Read More

Personalized medicine — the effort to tailor health care to individual patients’ needs, genetic profiles and circumstances — is a well-established concept at Vanderbilt University Medical Center. Read More

Walk into ophthalmologist Anita Agarwal’s office at the Vanderbilt Eye Institute and there is something remarkably different about the décor. Read More

Virtual reality environments are a common feature used in the aviation industry to train pilots, and now they’re also proving to be a very effective tool in educating the next generation of ophthalmological surgeons at Vanderbilt University Medical Center. Read More

An ion channel protein called TRIPV1 helps retinal neurons survive the elevated eye pressure associated with glaucoma. Read More